Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form S-3) and related Prospectus of Acasti Pharma Inc. for the registration of common shares and to the incorporation by reference therein of our report dated June 23, 2023, with respect to the consolidated financial statements of Acasti Pharma Inc. included in its Annual Report (Form 10-K) for the year ended March 31, 2023, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Montreal, Canada
October 6, 2023
